Home › Esophageal Adenocarcinoma › Minnesota › Duluth
Esophageal Adenocarcinoma clinical trials in Duluth, MN
3 studies for Esophageal Adenocarcinoma are looking for participants at sites in and around Duluth (within about 30 miles). Open a study to see who can join and how to contact the study team.
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
RecruitingPhase 2/3
- Essentia Health Cancer Center, Duluth
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Duluth
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
RecruitingPhase 3
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- and 1 more
Esophageal Adenocarcinoma trials in other cities
- New York City, NY18 studies
- Boston, MA13 studies
- Houston, TX12 studies
- Nashville, TN11 studies
- Arlington, VA11 studies
- Durham, NC10 studies
- Jacksonville, FL9 studies
- Baldwin Park, CA9 studies
- St. Louis, MO9 studies
- Queens, NY9 studies
- Los Angeles, CA9 studies
- Rochester, MN9 studies
Other studies in Duluth
- Non-Small Cell Lung Cancer13 studies
- Lung Cancer11 studies
- Breast Cancer7 studies
- Prostate Cancer7 studies
- Acute Myeloid Leukemia6 studies
- Colon Cancer6 studies
- Bladder Cancer6 studies
- Colorectal Cancer5 studies
- Melanoma5 studies
- Laryngeal Cancer5 studies
- Esophageal Cancer5 studies
- Rectal Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.